Free Trial

AbbVie (ABBV) News Today

AbbVie logo
$205.12 +2.40 (+1.18%)
Closing price 03/28/2025 03:59 PM Eastern
Extended Trading
$203.69 -1.43 (-0.70%)
As of 03/28/2025 07:46 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
AbbVie Inc. stock logo
O Shaughnessy Asset Management LLC Purchases 8,525 Shares of AbbVie Inc. (NYSE:ABBV)
O Shaughnessy Asset Management LLC boosted its position in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 4.0% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 222,691 shares of the company's stock after purchasing an addition
AbbVie Inc. stock logo
Clearbridge Investments LLC Sells 252,152 Shares of AbbVie Inc. (NYSE:ABBV)
Clearbridge Investments LLC lessened its holdings in AbbVie Inc. (NYSE:ABBV - Free Report) by 8.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 2,590,852 shares of the company's stock after selling 252,152 shares during the quarter.
AbbVie Inc. stock logo
Brandywine Global Investment Management LLC Decreases Stock Holdings in AbbVie Inc. (NYSE:ABBV)
Brandywine Global Investment Management LLC lessened its holdings in AbbVie Inc. (NYSE:ABBV - Free Report) by 7.2% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 1,069,571 shares of the company's stock after
AbbVie Inc. stock logo
CIBC Private Wealth Group LLC Sells 23,714 Shares of AbbVie Inc. (NYSE:ABBV)
CIBC Private Wealth Group LLC lowered its holdings in AbbVie Inc. (NYSE:ABBV - Free Report) by 2.2% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 1,054,103 shares of the company's stock after selling 23,714 shares during
AbbVie Inc. stock logo
AbbVie Inc. (NYSE:ABBV) Shares Sold by Mawer Investment Management Ltd.
Mawer Investment Management Ltd. reduced its stake in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 4.8% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 262,150 shares of the company's stock after
AbbVie Inc. stock logo
California Public Employees Retirement System Has $881.35 Million Stake in AbbVie Inc. (NYSE:ABBV)
California Public Employees Retirement System reduced its holdings in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 10.5% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 4,959,736 shares of the company's
AbbVie Inc. stock logo
RWA Wealth Partners LLC Acquires 4,664 Shares of AbbVie Inc. (NYSE:ABBV)
RWA Wealth Partners LLC boosted its stake in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 1.5% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 311,031 shares of the company's stock after acquiring an a
AbbVie Inc. stock logo
Schroder Investment Management Group Reduces Position in AbbVie Inc. (NYSE:ABBV)
Schroder Investment Management Group decreased its holdings in AbbVie Inc. (NYSE:ABBV - Free Report) by 8.9% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 2,426,105 shares of the company's stock after selling 235,739 shares during the qua
AbbVie Inc. stock logo
Best Biotech Stocks To Follow Today - March 29th
AbbVie, Thermo Fisher Scientific, Vertex Pharmaceuticals, Danaher, and Cencora are the five Biotech stocks to watch today, according to MarketBeat's stock screener tool. Biotech stocks are shares of companies that specialize in biotechnology—developing and commercializing products like pharmaceutic
AbbVie Inc. stock logo
Rep. Robert Bresnahan, Jr. Buys AbbVie Inc. (NYSE:ABBV) Shares
Representative Robert Bresnahan, Jr. (R-Pennsylvania) recently bought shares of AbbVie Inc. (NYSE:ABBV). In a filing disclosed on March 27th, the Representative disclosed that they had bought between $1,001 and $15,000 in AbbVie stock on February 25th. The trade occurred in the Representative's "JP
Financial markets news icon
MarketBeat Week in Review – 03/24 - 03/28 (ABBV)
Markets got a double dose of bad news about inflation and consumer confidence; next week, the Trump tariffs and Jobs report are likely to keep volatility high
AbbVie Inc. stock logo
95,560 Shares in AbbVie Inc. (NYSE:ABBV) Bought by Allianz SE
Allianz SE bought a new position in shares of AbbVie Inc. (NYSE:ABBV - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor bought 95,560 shares of the company's stock, valued at approximately $16,839,000. Other institutional in
AbbVie Inc. stock logo
Cambridge Financial Group Inc. Invests $6.81 Million in AbbVie Inc. (NYSE:ABBV)
Cambridge Financial Group Inc. acquired a new position in shares of AbbVie Inc. (NYSE:ABBV - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund acquired 38,303 shares of the company's stock, valued at approximately $6,80
AbbVie Inc. stock logo
Mitchell Sinkler & Starr PA Has $2.66 Million Holdings in AbbVie Inc. (NYSE:ABBV)
Mitchell Sinkler & Starr PA lessened its holdings in AbbVie Inc. (NYSE:ABBV - Free Report) by 46.8% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 14,984 shares of the company's stock after selling 13,165 shares during the qua
AbbVie Inc. stock logo
9,028 Shares in AbbVie Inc. (NYSE:ABBV) Acquired by Cornercap Investment Counsel Inc.
Cornercap Investment Counsel Inc. acquired a new stake in AbbVie Inc. (NYSE:ABBV - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 9,028 shares of the company's stock, valued at ap
AbbVie Inc. stock logo
State Farm Mutual Automobile Insurance Co. Has $1.06 Billion Stock Position in AbbVie Inc. (NYSE:ABBV)
State Farm Mutual Automobile Insurance Co. cut its stake in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 0.4% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 5,962,359 shares of the company's stock after selling 25,484 shares during the period. Ab
3 Relatively Safe Stocks to Buy Right Now
AbbVie Inc. stock logo
Allstate Corp Purchases 50,866 Shares of AbbVie Inc. (NYSE:ABBV)
Allstate Corp grew its holdings in AbbVie Inc. (NYSE:ABBV - Free Report) by 3,114.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 52,499 shares of the company's stock after acquiring an additional 50,866 shares during the quarter. A
AbbVie Inc. stock logo
Brown Brothers Harriman & Co. Grows Stock Holdings in AbbVie Inc. (NYSE:ABBV)
Brown Brothers Harriman & Co. boosted its holdings in AbbVie Inc. (NYSE:ABBV - Free Report) by 19.5% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 106,091 shares of the company's stock after buying an additional 17,
AbbVie Inc. stock logo
Pictet Asset Management Holding SA Raises Stake in AbbVie Inc. (NYSE:ABBV)
Pictet Asset Management Holding SA raised its holdings in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 3.4% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 817,389 shares of the company's stock after purchasing an additional
AbbVie Inc. stock logo
AbbVie (NYSE:ABBV) Shares Up 0.1% - Time to Buy?
AbbVie (NYSE:ABBV) Stock Price Up 0.1% - Still a Buy?
AbbVie Inc. stock logo
Promising Biotech Stocks To Watch Now - March 28th
AbbVie, Portage Biotech, Thermo Fisher Scientific, Vertex Pharmaceuticals, and Quantum Biopharma are the five Biotech stocks to watch today, according to MarketBeat's stock screener tool. Biotech stocks are shares in companies that focus on the development and commercialization of products based on
AbbVie Vs. Sanofi: Which Is The Better Investment Right Now
AbbVie Inc. stock logo
Level Four Advisory Services LLC Decreases Position in AbbVie Inc. (NYSE:ABBV)
Level Four Advisory Services LLC lowered its stake in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 5.6% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 127,149 shares of the company's stock after selling 7,570 shares during the quarter.
AbbVie Inc. stock logo
Vertex Planning Partners LLC Acquires 5,721 Shares of AbbVie Inc. (NYSE:ABBV)
Vertex Planning Partners LLC grew its holdings in AbbVie Inc. (NYSE:ABBV - Free Report) by 56.0% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 15,941 shares of the company's stock after purchasing an additional
AbbVie Inc. stock logo
denkapparat Operations GmbH Takes $484,000 Position in AbbVie Inc. (NYSE:ABBV)
denkapparat Operations GmbH purchased a new position in AbbVie Inc. (NYSE:ABBV - Free Report) during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 2,722 shares of the company's stock, valued at approximately $484,000. A number
AbbVie Inc. stock logo
Premier Fund Managers Ltd Has $1.35 Million Holdings in AbbVie Inc. (NYSE:ABBV)
Premier Fund Managers Ltd lifted its stake in AbbVie Inc. (NYSE:ABBV - Free Report) by 45.7% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 7,647 shares of the company's stock after acquiring an additio
AbbVie Inc. stock logo
AbbVie Inc. (NYSE:ABBV) Shares Purchased by Orion Portfolio Solutions LLC
Orion Portfolio Solutions LLC raised its holdings in AbbVie Inc. (NYSE:ABBV - Free Report) by 3.6% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 142,883 shares of the company's stock after acquiring an additional 4,961 sha
AbbVie Inc. stock logo
Nomura Asset Management Co. Ltd. Buys 95,711 Shares of AbbVie Inc. (NYSE:ABBV)
Nomura Asset Management Co. Ltd. lifted its stake in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 8.8% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 1,178,469 shares of the company's stock after acquiring an additional 95,711 shares during the period.
AbbVie Inc. stock logo
Frazier Financial Advisors LLC Grows Stake in AbbVie Inc. (NYSE:ABBV)
Frazier Financial Advisors LLC increased its stake in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 7.3% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 18,385 shares of the company's stock after purchasing an
AbbVie Inc. stock logo
Boussard & Gavaudan Investment Management LLP Acquires New Position in AbbVie Inc. (NYSE:ABBV)
Boussard & Gavaudan Investment Management LLP bought a new position in shares of AbbVie Inc. (NYSE:ABBV - Free Report) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 120,000 shares of the company's stock, valued
AbbVie Inc. stock logo
AbbVie Inc. (NYSE:ABBV) Shares Acquired by UniSuper Management Pty Ltd
UniSuper Management Pty Ltd increased its holdings in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 18.7% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 99,436 shares of the company's stock after purchasing an addition
AbbVie Inc. stock logo
AbbVie Inc. (NYSE:ABBV) Given Average Recommendation of "Moderate Buy" by Analysts
Shares of AbbVie Inc. (NYSE:ABBV - Get Free Report) have received an average rating of "Moderate Buy" from the twenty-five brokerages that are currently covering the company, MarketBeat Ratings reports. Five equities research analysts have rated the stock with a hold rating, seventeen have assigned
AbbVie Inc. stock logo
AbbVie (NYSE:ABBV) Shares Down 2.1% - Here's What Happened
AbbVie (NYSE:ABBV) Stock Price Down 2.1% - Here's Why
AbbVie Inc. stock logo
Promising Biotech Stocks To Watch Today - March 27th
AbbVie, Thermo Fisher Scientific, Danaher, Vertex Pharmaceuticals, Royalty Pharma, Moderna, and IQVIA are the seven Biotech stocks to watch today, according to MarketBeat's stock screener tool. Biotech stocks are shares of companies that focus on research and development in the biotechnology field,
AbbVie Inc. stock logo
AbbVie (NYSE:ABBV) Trading Up 0.9% - Here's What Happened
AbbVie (NYSE:ABBV) Stock Price Up 0.9% - Here's What Happened
AbbVie Inc. stock logo
Norges Bank Buys Shares of 25,095,020 AbbVie Inc. (NYSE:ABBV)
Norges Bank acquired a new stake in shares of AbbVie Inc. (NYSE:ABBV - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 25,095,020 shares of the company's stock, valu
AbbVie Inc. stock logo
Caisse Des Depots ET Consignations Invests $10.56 Million in AbbVie Inc. (NYSE:ABBV)
Caisse Des Depots ET Consignations purchased a new stake in shares of AbbVie Inc. (NYSE:ABBV - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm purchased 59,427 shares of the company's stock, valued at approximately $10,560,000. AbbVie accounts
AbbVie Inc. stock logo
Blair William & Co. IL Purchases 29,771 Shares of AbbVie Inc. (NYSE:ABBV)
Blair William & Co. IL increased its holdings in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 2.5% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 1,201,107 shares of the company's stock after purchasing an additional 29,771 shares during the period. Blair
AbbVie Inc. stock logo
AbbVie Inc. (NYSE:ABBV) Holdings Increased by Homestead Advisers Corp
Homestead Advisers Corp increased its stake in AbbVie Inc. (NYSE:ABBV - Free Report) by 3.9% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 712,660 shares of the company's stock after acq
AbbVie Inc. stock logo
AbbVie Inc. (NYSE:ABBV) Position Trimmed by Delta Asset Management LLC TN
Delta Asset Management LLC TN reduced its holdings in AbbVie Inc. (NYSE:ABBV - Free Report) by 3.7% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 35,835 shares of the company's stock after selling 1,388 shares during the quarter. Delta As
AbbVie Inc. stock logo
Howe & Rusling Inc. Increases Stock Position in AbbVie Inc. (NYSE:ABBV)
Howe & Rusling Inc. grew its position in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 14.2% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 83,647 shares of the company's stock after acquiring an addit
AbbVie Inc. stock logo
AssuredPartners Investment Advisors LLC Takes $1.20 Million Position in AbbVie Inc. (NYSE:ABBV)
AssuredPartners Investment Advisors LLC acquired a new position in AbbVie Inc. (NYSE:ABBV - Free Report) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm acquired 6,762 shares of the company's stock, valued at approximately $1,202,000. A
AbbVie Inc. stock logo
NEOS Investment Management LLC Increases Stock Position in AbbVie Inc. (NYSE:ABBV)
NEOS Investment Management LLC lifted its stake in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 30.5% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 95,789 shares of the company's stock after purchasi
AbbVie Inc. stock logo
Amica Mutual Insurance Co. Cuts Stock Holdings in AbbVie Inc. (NYSE:ABBV)
Amica Mutual Insurance Co. lessened its holdings in AbbVie Inc. (NYSE:ABBV - Free Report) by 9.9% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 26,684 shares of the company's stock after selling 2,932 sh
AbbVie Inc. stock logo
Moment Partners LLC Acquires Shares of 5,779 AbbVie Inc. (NYSE:ABBV)
Moment Partners LLC bought a new position in shares of AbbVie Inc. (NYSE:ABBV - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund bought 5,779 shares of the company's stock, valued at approximately $1,027,000. A number of other large
AbbVie Inc. stock logo
Sava Infond d.o.o. Invests $1.89 Million in AbbVie Inc. (NYSE:ABBV)
Sava Infond d.o.o. bought a new stake in AbbVie Inc. (NYSE:ABBV - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 10,616 shares of the company's stock, valued at approximately $1,886,000. Several other l
AbbVie Inc. stock logo
Elo Mutual Pension Insurance Co Has $28.64 Million Stock Position in AbbVie Inc. (NYSE:ABBV)
Elo Mutual Pension Insurance Co cut its position in AbbVie Inc. (NYSE:ABBV - Free Report) by 4.0% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 161,192 shares of the company's stock after selling 6,634 sh
Remove Ads
Get AbbVie News Delivered to You Automatically

Sign up to receive the latest news and ratings for ABBV and its competitors with MarketBeat's FREE daily newsletter.

ABBV Media Mentions By Week

ABBV Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ABBV
News Sentiment

1.27

0.81

Average
Medical
News Sentiment

ABBV News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ABBV Articles
This Week

100

44

ABBV Articles
Average Week

Remove Ads
Get AbbVie News Delivered to You Automatically

Sign up to receive the latest news and ratings for ABBV and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NYSE:ABBV) was last updated on 3/30/2025 by MarketBeat.com Staff
From Our Partners